FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Kadmon Plans NDA for Graft-Versus-Host Disease

Kadmon Holdings gets FDA meeting minutes on a planned NDA submission for KD025 for treating patients with chronic graft-versus-host disease.

Medical Devices

Emergency Psych Digital Health Device Guidance

FDA issues an immediately effective enforcement discretion policy for some digital medical devices used to treat psychiatric disorders during the pand...

Human Drugs

Warning Letter Against Herbal Products for Covid-19

FDA issues Herbs of Kedem a Warning Letter after reviewing the companys Web site and determining that it is offering for sale unapproved new drugs for...

Deadline Extended on Real-World Data Opportunity

FDA extends its deadline until 6/5 to apply for a funding opportunity to examine the use of real-world data to generate real-world evidence in regulat...

Medical Devices

Hahn Contradicts Trump on Need for Widespread Testing

FDA commissioner Steve Hahn indirectly contradicts President Trump, telling ABC News that ramping up caronavirus testing, both diagnostic and new anti...

Federal Register

FDA Policy Allows Diabetics Self Testing in Hospital

FDA allows the use of home-use blood glucose meters by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose le...

Federal Register

ANDA Guides for Chloroquine/Hydroxychloroquine

Federal Register notice: FDA makes available two final guidances entitled Guidance on Chloroquine Phosphate and Guidance on Hydroxychloroquine Sulfate...

Human Drugs

Small Remdesivir Study Sees Promising Results

A just-published study report on the compassionate use of Gileads investigational remdesivir in Covid-19 patients shows improvement in oxygen-support ...

Medical Devices

Guide on Companion Diagnostics for Oncology Products

FDA posts a final guidance on developing and labeling In vitro companion diagnostic devices for oncology Products.

Medical Devices

BD gets Emergency Use for Covid-19 Test

FDA grants BD an emergency use authorization for a molecular diagnostic test for Covid-19 that can return results in two to three hours.